Verastem Inc VSTM:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 05/20/24 EDT
11.61quote price arrow up+0.11 (+0.96%)
Volume
73,812
52 week range
4.93 - 15.18
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11.61
  • 52 Week High15.18
  • 52 Week High Date05/30/23
  • 52 Week Low4.93
  • 52 Week Low Date05/25/23

Key Stats

  • Market Cap293.822M
  • Shares Out25.31M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta0.43
  • YTD % Change42.63

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11.61
  • 52 Week High15.18
  • 52 Week High Date05/30/23
  • 52 Week Low4.93
  • 52 Week Low Date05/25/23
  • Market Cap293.822M
  • Shares Out25.31M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta0.43
  • YTD % Change42.63

RATIOS/PROFITABILITY

  • EPS (TTM)-4.39
  • P/E (TTM)-2.64
  • Fwd P/E (NTM)-3.03
  • EBITDA (TTM)-100.048M
  • ROE (TTM)-363.30%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,843.30%
  • Debt To Equity (MRQ)88.78%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Verastem Inc

 

Profile

MORE
Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition. The Company’s advanced product candidates, avutometinib and defactinib, are being investigated in both...
Daniel Paterson
President, Chief Executive Officer, Director
Daniel Calkins
Chief Financial Officer, Controller
Address
117 Kendrick Street, Suite 500
Cambridge, MA
02494
United States

Top Peers

SYMBOLLASTCHG%CHG
OPT
Opthea Ltd
3.46+0.05+1.47%
VTYX
Ventyx Biosciences Inc
4.83+0.10+2.11%
ATAI
ATAI Life Sciences NV
1.73+0.02+1.17%
INZY
Inozyme Pharma Inc
4.73+0.13+2.83%
ERAS
Erasca Inc
2.24+0.27+13.71%